Apollon Wealth Management LLC Sells 156 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Apollon Wealth Management LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% in the 4th quarter, HoldingsChannel reports. The fund owned 10,380 shares of the medical equipment provider’s stock after selling 156 shares during the period. Apollon Wealth Management LLC’s holdings in Intuitive Surgical were worth $5,418,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several analyst reports. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $582.98 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $207.65 billion, a P/E ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. The stock has a 50-day simple moving average of $554.85 and a two-hundred day simple moving average of $513.96.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock worth $3,333,485 in the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.